$3.57
00.00%
Last update: Jul 19, 4:01 PM
15 minutes delayed
Atea Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Atea Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AVIR | Atea Pharmaceuticals | -$0.34 | -$0.76 | — | — | $0.00 | — | — | — | 08/06/2024 | Get Alert |
AVIR | Atea Pharmaceuticals | -$0.43 | -$0.61 | -$0.75 | -22.95% | $0.00 | — | $0.00 | — | 05/14/2024 | Get Alert |
AVIR | Atea Pharmaceuticals | -$0.41 | -$0.50 | -$0.47 | 6.00% | $0.00 | — | $0.00 | — | 02/28/2024 | Get Alert |
AVIR | Atea Pharmaceuticals | -$0.10 | -$0.48 | -$0.40 | 16.67% | $0.00 | — | $0.00 | — | 11/08/2023 | Get Alert |
AVIR | Atea Pharmaceuticals | -$0.38 | -$0.47 | -$0.34 | 27.66% | $0.00 | — | $0.00 | — | 08/08/2023 | Get Alert |
AVIR | Atea Pharmaceuticals | -$0.51 | -$0.48 | -$0.43 | 10.42% | $0.00 | — | $0.00 | — | 05/08/2023 | Get Alert |
AVIR | Atea Pharmaceuticals | $1.34 | -$0.45 | -$0.41 | 8.89% | $192.18M | — | $0.00 | — | 02/28/2023 | Get Alert |
AVIR | Atea Pharmaceuticals | -$0.34 | -$0.44 | -$0.10 | 77.27% | $32.81M | — | $0.00 | — | 11/07/2022 | Get Alert |
AVIR | Atea Pharmaceuticals | $0.02 | -$0.52 | -$0.38 | 26.92% | $60.39M | — | $0.00 | — | 08/08/2022 | Get Alert |
AVIR | Atea Pharmaceuticals | $0.34 | -$0.58 | -$0.51 | 12.07% | $65.98M | $3.33M | $0.00 | -100.00% | 05/10/2022 | Get Alert |
AVIR | Atea Pharmaceuticals | $0.95 | $0.17 | $1.34 | 688.24% | $48.63M | $85.73M | $192.18M | 124.17% | 02/28/2022 | Get Alert |
AVIR | Atea Pharmaceuticals | -$1.74 | -$0.24 | -$0.34 | -41.67% | $0.00 | — | $32.81M | — | 11/11/2021 | Get Alert |
AVIR | Atea Pharmaceuticals | -$0.99 | — | $0.02 | — | — | $57.99M | $60.39M | 4.14% | 08/12/2021 | Get Alert |
AVIR | Atea Pharmaceuticals | — | $0.16 | $0.34 | 112.50% | — | $48.63M | $65.98M | 35.69% | 05/13/2021 | Get Alert |
AVIR | Atea Pharmaceuticals | — | $0.16 | $0.95 | 493.75% | — | $45.00M | $48.63M | 8.07% | 03/30/2021 | Get Alert |
AVIR | Atea Pharmaceuticals | — | — | -$1.74 | — | — | — | $0.00 | — | 12/10/2020 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $-0.75 | $-0.61 | -22.9 % |
Dec 2023 | 2024-02-28 | $-0.47 | $-0.50 | 6.00 % |
Sep 2023 | 2023-11-08 | $-0.40 | $-0.48 | 16.7 % |
Jun 2023 | 2023-08-08 | $-0.34 | $-0.47 | 27.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2022 | 2022-05-10 | $0 | $3.33M | -100.0 % |
Dec 2021 | 2022-02-28 | $192.18M | $85.73M | 124.2 % |
Jun 2021 | 2021-08-12 | $60.39M | $57.99M | 4.14 % |
Mar 2021 | 2021-05-13 | $65.99M | $48.63M | 35.7 % |
Atea Pharmaceuticals (AVIR) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
The Actual EPS was $-0.75, which missed the estimate of $-0.61.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.